Application Note: Rapid Identification of Diverse High-Affinity SARS-CoV-2 Antibodies
Learn about the latest advances in antibody discovery that can help maximize your chances of identifying the ideal mAbs for your research applications!
In this application note, we detail how a diverse range of high-affinity, high-specificity SARS-CoV-2 Spike/RBD mAbs was discovered in just 24 hours to accelerate therapeutic, diagnostic, vaccine, and basic research immunoassay development.
- Accelerated discovery of high-affinity, highly diverse SARS-CoV-2 Spike/RBD rabbit mAbs via single B cell screening within 24 hours
- Larger antibody diversity achieved through single B cell screening compared to hybridoma technology
- Diverse mAbs that recognize multiple unique epitopes are critical for optimal immunoassay development, including sandwich ELISA to a sensitivity of 20 pg/ml